But there are some easy wins being left on the table, say consultants
Over the last two years, pharmaceutical giant GSK has shifted its approach to ESG engagement. While the company used to focus on managing incoming requests, it is now much more proactive. A case in point: just last week it held a webinar on its latest ESG data and ran a sustainability-focused roadshow, targeting a global mix of investors.
The change is indicative of how IR teams have taken control of ESG engagement. They have brought structure and efficiency to how companies interact with investors
You need to register to access 3 free deep dive articles per month. To continue reading please register or login below..
- Unlimited deep dives
- Data-driven research around key topics
- Buy-side insights
- Benchmarking reports
From
$1495
Tim Human
Senior reporter
